Nifedipine inhibits hypoxia induced transvascular leakage through down regulation of NFkB

Respiratory Physiology and Neurobiology

Volumn 183, Issue 1, 2012, Pages 26-34

  Sarada, S K S ^a   Veeramohan, Himadri P ^a   Mathew, Titto ^a   Saumya, S ^a   Chitharanjan, M ^a  

^a DEFENCE INSTITUTE OF PHYSIOLOGY AND ALLIED SCIENCES   (India)

Author keywords

Hypoxia; Inflammation; NFkB; Nifedipine; Oxidative stress; Pulmonary edema; ROS

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; NIFEDIPINE; PADGEM PROTEIN; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; DOWN REGULATION; HYPOXIA; LUNG; LUNG EDEMA; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION;

ALTITUDE SICKNESS; ANIMALS; ANOXIA; CALCIUM CHANNEL BLOCKERS; CAPILLARY PERMEABILITY; DISEASE MODELS, ANIMAL; DOWN-REGULATION; HYPERTENSION, PULMONARY; INFLAMMATION; MALE; NF-KAPPA B; NIFEDIPINE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84863429438     PISSN: 15699048     EISSN: 18781519     Source Type: Journal    
DOI: 10.1016/j.resp.2012.05.016     Document Type: Article

References (60)

1. Abraham E. NFkB activation. Critical Care Medicine 2000, 28:100-104.
2. Antezana A.M., Antezana G., Aparicio O., Noriega I., Velarde F.L., Richalet J.P. Pulmonary hypertension in high-altitude chronic hypoxia: response to nifedipine. European Respiratory Journal 1998, 1184.
3. Baba M., Oshi R., Saeki K. Enhancement of blood brain barrier permeability to sodium fluorescence by stimulation of mu opiod receptors in mice. Naunyn-Schmiedeberg's Archives of Pharmocology 1998, 337:423-428.
4. Baeuole P.A., Baltimore D. NFkB: ten years after. Cell 1996, 87:13-20.
5. Bartsch P., Vock P., Maggiorini M., Franciolli M., Fretz C., Schobersberger W., et al. Respiratory symptoms, radiographic and physiologic correlations at high altitude. Hypoxia: The Adaptation 1990, 241-245. Decker, Philadelphia. J.R. Sotton, G. Coates, J.E. Remmers (Eds.).
6. Bartsch P., Naggiorini M., Ritter M., Noti C., Vock P., Oclz O. Prevention of high altitude pulmonary edema by nifedipine. New England Journal of Medicine 1991, 325:1284-1289.
7. Bartsch P., Maribauri H., Maggiorini M., Swensan E.R. Physiological aspects of high altitude pulmonary edema. Journal of Applied Physiology 2005, 98:1101-1110.
8. Bartsch P. High altitude pulmonary edema. Respiration 1997, 64(6):435-443.
9. Brennan F.M., Miani R.N., Feldmann M. Cytokine expression in chronic inflammatory disease. British Medical Bulletin 1995, 51:368-384.
10. Colleen G.J., Andrew W.S., Megan J.W., Andrew C.D., Travis P., Robert C.R. Acute mountain sickness, inflammation and permeability: new insights from a blood biomarker study. Journal of Applied Physiology 2011, 111(2):392-399.
11. Dehler M., Zessin E., Bartsch P., Mairbaurl H. Hypoxia causes permeability oedema in the constant-pressure perfused rat lung. European Respiratory Journal 2006, 27(3):600-606.
12. Dehnert C., Gruing E., Mereles D., Von Lennep.N., Bartsch P. Identification of individuals susceptible to high altitude pulmonary oedema at low altitude. European Respiratory Journal 2005, 25(3):545-551.
13. Erdmann A.J., Vaughan T.R., Brigham K.L., Woolverton W.C., Staub N.C. Effect of increased vascular pressure on lung fluid balance in unanesthetised sheep. Circulation Research 1975, 37:271-284.
14. Freeman B.A., Crapo J.D. Biology of disease: free radicals and tissue injury. Laboratory Investigation 1982, 47(5):412-426.
15. Gonalez N.C., Wood J.G. Leucocyte-endothelial interactions in environmental hypoxia. Advances in Experimental Medicine and Biology 2001, 502:39-60.
16. Hackett P.H., Rennie D. Rales, peripheral edema, retinal hemorrhage and acute mountain sickness. American Journal of Medicine 1979, 67:214-218.
17. Hackett P.H., Roach R.C. High altitude cerebral edema. High Altitude Medicine and Biology 2004, 5:136-146.
18. Helmut S. Glutathione and its role in cellular functions. Free Radical Biology and Medicine 1999, 27:916-921.
19. Hohenhaus E., Niroomand F., Goerre S., Vock P., Oelzo B., Artsula P. Nifedipine does not prevent acute mountain sickness. American Journal of Respiratory and Critical Care Medicine 1994, 150(3):857-860.
20. Hopkins S.R., Garg J., Divya S.B., Jamal B., David L.L. Pulmonary blood flow heterogeneity during hypoxia and high-altitude pulmonary edema. American Journal of Respiratory and Critical Care Medicine 2005, 171:83-87.
21. Houston C.S. Acute pulmonary edema of high altitude. New England Journal of Medicine 1960, 263:478-480.
22. Hultgren H.N., Lopez C.E., Lundberg E., Miller H. Physiologic studies of pulmonary edema at high altitude. Circulation 1964, 29:393-408.
23. Irfan R. Oxidative stress, transcription factors and chromatin remodeling in lung inflammation. Biochemical Pharmacology 2002, 64:935-942.
24. Kleger G., Bartsch P., Vock P. Evidence against an increase in capillary permeability in subjects exposed to high altitude. Journal of Applied Physiology 1996, 81:1917-1923.
25. Kobayashi T., Koyama S., Kubo K., Fukushima M., Kusama S. Clinical features of patients with high altitude pulmonary edema in Japan. Chest 1987, 92:814-821.
26. Kubo K., Hanaoka M., Yamaguchi S. Cytokines in bronchoalveolar lavage fluid in patients with high altitude pulmonary edema at moderate altitude in Japan. Thorax 1996, 51:739-742.
27. Kubo K., Hanaoka M., Hayano T., Miyahara T., Hachiya T., Hayasaka M., Koizumi T., Fujimoto K., Kobayashi T., Honda T. Inflammatory cytokines in BAL fluid and pulmonary haemodynamics in high altitude pulmonary edema. Respiration Physiology 1998, 111:301-310.
28. Kum-Talt L., Tan I.K. A new calorimetric method for the determination of glutathione in erythrocytes. Clinical Chemistry Acta 1974, 53:153-161.
29. Loaldi A., Polese A., Montorsi P., Decesare N., Fabbiocchi F., Ravagnani P., Guazzi M.D. Comparison of nifedipine, propanol, and isosorbide dinitrate on angiographic progression and regression of coronary arterial narrowing in angina pectoris. American Journal of Cardiology 1989, 64:433-439.
30. Le Bel C., Ali S., Mc Kee M., Bondy S. Organometal induced increases in oxygen reactive species: the potential of 2,7-dichloroflurescein diacetate as an index of neurotoxic damage. Toxicology and Applied Pharmacology 1990, 104:17-24.
31. Lowry O.H., Rosebrough N.J., Randall R.J. Protein measurement with folin phenol reagent. Journal of Biological Chemistry 1951, 193:265-275.
32. Maggiorini M., Buhler B., Walter M., Oelz O. Prevalence of acute mountain sickness in the Swiss Alps. BMJ 1990, 301:853-855.
33. Maggiorini M., Melot C., Pierre S., et al. High altitude pulmonary edema is initially caused by increase in capillary pressure. Circulation 2001, 103:2078-2083.
34. Maggiorini M. High altitude-induced pulmonary edema. Review. Cardiovascular Research 2006, 72:41-50.
35. Maggiorini M., Brunner-La Rocca H.P., Peth S., et al. Both tadalafil and dexamethasone may reduce the incidence of high altitude pulmonary edema. A randomized trial. Annals of Internal Medicine 2006, 145:497-506.
36. Matusi H., Ihara Y., Fujio Y., Kunisada K., Akira S., Kishimoto T., Yamauchi-Takihara K. Induction of interleukin (IL-1) by hypoxia is mediated by nuclear factor kappa b and NF-IL-6 in cardiac myocytes. Cardiovascular Research 1999, 42:104-112.
37. Meister A., Anderson M.E. Glutathione. Annual Review of Biochemistry 1983, 5:711-760.
38. Nico A.M., Alex F., de Vos M.C., Dessing C., Arnold S.R., Lutter H.M., Jaring S., Van der Z., Paul B., Tom P. Anti-inflammatory effect of salmeterol after inhalation of lipopolysaccharide by healthy volunteers. American Journal of Respiratory and Critical Care Medicine 2005, 172:878-884.
39. Oelz O., Maggiorini M., Ritter M., Noti C., Waber U., Vock P., Bartscu P. Nifedipine for high altitude pulmonary edema. Lancet 1989, 2:1241-1244.
40. Oelz O., Maggiorini M., Ritter M., Noti C., Waber U., Vock P., Bartscu P. Prevention and treatment of high altitude pulmonary edema by a calcium channel bloker. International Journal of Sports Medicine 1992, 13(1):565-568.
41. Okhawa H., Oshini N., Yagi K. Assay for lipid peroxidases in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry 1979, 95:351-358.
42. Ono S., Westcott J.Y., Chang W., Voelkel N.F. Endotoxin priming followed by high altitude causes pulmonary edema in rats. Journal of Applied Physiology 1993, 74:1534-1542.
43. Peter R., Jan M.S., Valbona M., Eva M., Alice M., Julio C.M.G., Klaus U., Holger K.E. Hypoxia-inducible factor-dependent induction of netrin-1 dampens inflammation caused by hypoxia. Nature Immunology 2009, 10(2):195-202.
44. Punchard N.A., Kelly F.J. Free Radicals a Practical Approach 1996, Oxford University Press, pp .126-130.
45. Roumeguère T., Zouaoui K., Babar S., Nuyens V., Rousseau A., Van Antwerpen P., Ducobu J., Wespes E., Vanhaeverbeek M. Effects of phosphodiesterase inhibitors on the inflammatory response of endothelial cells stimulated by myeloperoxidase-modified low-density lipoprotein or tumor necrosis factor alpha. European Urology 2010, 57(3):522-528.
46. Sarada S.K.S., Dipti P., Anju B., Pauline T., Kain A.K., Sairam M., Sharma, Ilavazhagan S.K., Devendra Kumar G., Selvamurthy W. Antioxidant effect of beta-carotene on hypoxia induced oxidative stress in male albino rats. Journal of Ethanopharmocology 2002, 79:149-153.
47. Sarada S., Himadri P., Mishra C., Geetali P., Ram M.S., Ilavazagan G. Role of oxidative stress and NFkB in hypoxia induced pulmonary edema. Experimental Biology and Medicine 2008, 233:1088-1098.
48. Sartori C., Lipp E., Duplain H., Allemann Y., Lepori M., Egli M. Prevention of HAPE by beta adrenergic stimulation of the alveolar epithelial sodium transport. American Journal of Critical Care Medicine 2000, 161:A415S.
49. Sartori C., Allemann Y., Trueb L., Lepori M., Nicod P., Scherrer U. Exaggerated pulmonary hypertension is not sufficient to trigger high-altitude pulmonary edema in humans. Schweizerische Medizinische Wochenschrift. Journal Suisse de Medecine 2000, 130(11):385-389.
50. Sawatzky D.A., Megson I.L., Rossi A.G. Sildenafil offers protection against NSAID-induced gastric injury. British Journal of Pharmacology 2005, 146:477-478.
51. Scherrer U., Rexhaj E., jayet P., Sartori y.C. New insights in the pathogenesis of high altitude pulmonary edema. Progress in Cardiovascular Diseases 2010, 52(6):485-492.
52. Schoene R.B., Swenson E.R., Pizzo C.J., Hackett P.H., Roach R.C., Mills W.J., Henderson W.R., Martin T.R. The lung at high altitude: bronchoalveolar lavage in acute mountain sickness and pulmonary edema. Journal of Applied Physiology 1988, 64:2605-2613.
53. Senftleben U., Karin M. The IKK/NFkB pathway. Critical Care Medicine 2002, 30:16-18.
54. Singh I., Roy S.B. High altitude pulmonary edema: Clinical, hemodynamic and pathological studies. Biomedicine Problems of High Terrestrial Elevation Problems 1969, 108-120. US Army Research and Development Command, Washington D.C. E. Hegnauer (Ed.).
55. Sophocles A.M. High altitude pulmonary edema in vail, Colorodo, 1975-1982. High Altitude Medicine and Biology 1986, 144:569-573.
56. Stelzner T.J., O'Brien R.F., Sato K., Weil J.V. Hypoxia induced increase in pulmonary transvascular protein escape in rats. Modulation by glucocorticoids. Journal of Clinical Investigation 1988, 82:1840-1847.
57. Swenson E.R., Maggiorini M., Mangovins, Gibbs J.S., Greve I., Mairbaurl H., Bartsch P. Pathogenesis of high altitude pulmonary edema: inflammation is not an etiologic factor. JAMA 2002, 287:28-35.
58. Takase H., Toriyama T., Sugiyama M., Nakazawa A.I., Hayashi K., Goto T., Sugiura T., Ikeda K., Sato K., Ueda R., Dohi Y. Effect of nifedipine on C-reactive protein levels in the coronary sinus and on coronary blood flow in response to acetylcholine in patients with stable angina pectoris having percutaneous coronary intervention. American Journal of Cardiology 2005, 95:1235-1237.
59. Yoshinari D., Takeyoshi I., Koibuchi Y., Matsumoo K., Kawashima Y., Koyama T., Ohwada S., Morishita Y. Effects of a dual inhibitor of tumor necrosis factor-α and interleukin-1 on lipopolysaccharide-induced lung injury inrats: involvement of p38 mitogen-activated protein kinase pathway. Critical Care Medicine 2001, 29:628-634.
60. Younes M., Kayser E., Strubelt O. Effect of antioxidants on hypoxia/regeneration-induced injury in isolated perfused rat liver. Pharmacology and Toxicology 1992, 71:278-283.